Most Recent

image: Angela Brooks: Splicing Specialist

Angela Brooks: Splicing Specialist

By | April 1, 2017

At the University of California, Santa Cruz, the researcher combs the cancer genome, looking for weaknesses.

0 Comments

image: Vlad Denic on Exploring New Fields and Failing Successfully

Vlad Denic on Exploring New Fields and Failing Successfully

By | December 1, 2016

The Harvard professor is pursuing fundamental questions about autophagy, protein homeostasis, and other cellular processes, and he’s always on the lookout for his next new topic.

2 Comments

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

Instructor, Department of Systems Biology, University of Texas MD Anderson Cancer Center. Age: 38

1 Comment

image: Gia Voeltz: Cellular Cartographer

Gia Voeltz: Cellular Cartographer

By | December 1, 2015

Associate Professor, Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder. Age: 43

0 Comments

image: Yvonne Saenger: Immunotherapy Pioneer

Yvonne Saenger: Immunotherapy Pioneer

By | April 1, 2015

Assistant Professor, Department of Medicine, Columbia University. Age: 41

5 Comments

image: Weiwei Dang: Epigenetics in Aging

Weiwei Dang: Epigenetics in Aging

By | March 1, 2015

Assistant Professor, Huffington Center On Aging, Baylor College of Medicine. Age: 38

0 Comments

image: Sophie Dumont: Forces at Play

Sophie Dumont: Forces at Play

By | May 1, 2014

Assistant Professor, Department of Cell & Tissue Biology, University of California, San Francisco. Age: 38

0 Comments

image: Maria Spies: Molecular Machinist

Maria Spies: Molecular Machinist

By | April 1, 2014

Associate Professor, Biochemistry, University of Iowa, Age: 40

0 Comments

image: Erica Larschan: Hitting Her Targets

Erica Larschan: Hitting Her Targets

By | November 1, 2012

Assistant Professor, Molecular Biology, Cell Biology, & Biochemistry Brown University, Age: 36

1 Comment

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS